Holen Sie sich die Stockscreener-App
73.17
0.26%
0.19
Vorhandelsmarkt:
73.10
-0.07
-0.10%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt CTVA?
Forum
Prognose
Dividendenhistorie
Schlusskurs vom Vortag:
$72.98
Offen:
$73.02
24-Stunden-Volumen:
2.69M
Relative Volume:
0.71
Marktkapitalisierung:
$49.91B
Einnahmen:
$16.83B
Nettoeinkommen (Verlust:
$1.14B
KGV:
44.62
EPS:
1.64
Netto-Cashflow:
$2.10B
1W Leistung:
-2.22%
1M Leistung:
-1.40%
6M Leistung:
+17.41%
1J Leistung:
+31.74%
1-Tages-Spanne:
$72.66
$73.54
1-Wochen-Bereich:
$71.78
$74.45
52-Wochen-Spanne:
$50.30
$77.41
Corteva Inc Stock (CTVA) Company Profile
Firmenname
Corteva Inc
Sektor
Branche
Telefon
(833) 267-8382
Adresse
9330 ZIONSVILLE ROAD, INDIANAPOLIS, DE
Vergleichen Sie CTVA mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CTVA
Corteva Inc
|
73.17 | 51.05B | 16.83B | 1.14B | 2.10B | 1.64 |
|
NTR
Nutrien Ltd
|
58.32 | 29.64B | 25.68B | 527.00M | 839.00M | 1.07 |
|
CF
Cf Industries Holdings Inc
|
91.79 | 15.51B | 6.13B | 1.34B | 1.86B | 7.59 |
|
MOS
Mosaic Company
|
35.27 | 11.40B | 11.06B | 367.80M | 212.50M | 1.16 |
|
ICL
Icl Group Ltd
|
6.75 | 9.14B | 6.84B | 407.00M | 755.00M | 0.32 |
Corteva Inc Stock (CTVA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-03-31 | Hochstufung | Argus | Hold → Buy |
| 2025-03-13 | Eingeleitet | Goldman | Buy |
| 2024-10-23 | Eingeleitet | Citigroup | Buy |
| 2024-10-16 | Hochstufung | BofA Securities | Neutral → Buy |
| 2024-08-07 | Herabstufung | Argus | Buy → Hold |
| 2024-04-12 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2024-03-01 | Eingeleitet | Wolfe Research | Outperform |
| 2024-02-12 | Hochstufung | Loop Capital | Hold → Buy |
| 2024-02-02 | Hochstufung | Exane BNP Paribas | Underperform → Neutral |
| 2023-11-27 | Herabstufung | Berenberg | Buy → Hold |
| 2023-11-14 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2023-10-20 | Hochstufung | Oppenheimer | Perform → Outperform |
| 2023-09-05 | Hochstufung | UBS | Neutral → Buy |
| 2023-07-25 | Herabstufung | Redburn | Buy → Neutral |
| 2023-06-28 | Eingeleitet | Canaccord Genuity | Buy |
| 2023-05-22 | Hochstufung | Vertical Research | Hold → Buy |
| 2023-04-06 | Eingeleitet | Oppenheimer | Perform |
| 2023-01-19 | Eingeleitet | Wells Fargo | Overweight |
| 2023-01-11 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2022-11-16 | Herabstufung | UBS | Buy → Neutral |
| 2022-11-15 | Herabstufung | Loop Capital | Buy → Hold |
| 2022-08-08 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2022-08-08 | Hochstufung | ROTH Capital | Neutral → Buy |
| 2022-07-14 | Eingeleitet | Credit Suisse | Outperform |
| 2022-06-01 | Eingeleitet | Barclays | Overweight |
| 2022-05-06 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2022-04-14 | Hochstufung | Loop Capital | Hold → Buy |
| 2022-04-14 | Herabstufung | Vertical Research | Buy → Hold |
| 2022-01-31 | Hochstufung | Redburn | Neutral → Buy |
| 2021-10-18 | Herabstufung | Loop Capital | Buy → Hold |
| 2021-10-13 | Eingeleitet | Mizuho | Buy |
| 2021-10-08 | Eingeleitet | ROTH Capital | Buy |
| 2021-09-01 | Eingeleitet | Berenberg | Buy |
| 2021-08-09 | Hochstufung | Monness Crespi & Hardt | Sell → Neutral |
| 2021-05-10 | Herabstufung | BofA Securities | Buy → Underperform |
| 2021-04-19 | Hochstufung | Loop Capital | Hold → Buy |
| 2021-02-05 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2021-02-05 | Bestätigt | Monness Crespi & Hardt | Sell |
| 2020-12-18 | Herabstufung | Susquehanna | Positive → Neutral |
| 2020-12-14 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2020-11-10 | Hochstufung | Argus | Hold → Buy |
| 2020-10-19 | Hochstufung | BofA Securities | Neutral → Buy |
| 2020-10-19 | Herabstufung | Exane BNP Paribas | Outperform → Underperform |
| 2020-08-11 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2020-08-10 | Herabstufung | BofA Securities | Buy → Neutral |
| 2020-07-13 | Hochstufung | BofA Securities | Underperform → Buy |
| 2020-06-26 | Eingeleitet | Cleveland Research | Neutral |
| 2020-06-16 | Hochstufung | Vertical Research | Hold → Buy |
| 2020-06-08 | Herabstufung | Monness Crespi & Hardt | Neutral → Sell |
| 2020-05-11 | Herabstufung | BofA/Merrill | Neutral → Underperform |
| 2020-04-17 | Herabstufung | BofA/Merrill | Buy → Neutral |
| 2020-04-17 | Hochstufung | Loop Capital | Sell → Hold |
| 2020-04-01 | Hochstufung | Exane BNP Paribas | Neutral → Outperform |
| 2020-03-31 | Hochstufung | Susquehanna | Neutral → Positive |
| 2020-03-26 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2020-03-19 | Hochstufung | Edward Jones | Hold → Buy |
| 2020-03-13 | Hochstufung | BofA/Merrill | Neutral → Buy |
| 2020-03-10 | Hochstufung | Monness Crespi & Hardt | Sell → Neutral |
Alle ansehen
Corteva Inc Aktie (CTVA) Neueste Nachrichten
Is Corteva Inc. a good long term investmentRapid wealth accumulation - Jammu Links News
Lobbying Update: $900,000 of CORTEVA AGRISCIENCE LLC (FKA E I DU PONT DE NEMOURS AND COMPANY) lobbying was just disclosed - Quiver Quantitative
Corteva's Quarterly Earnings Preview: What You Need to Know - MSN
Corteva, Inc. (CTVA) Upgraded to Strong Buy: What Does It Mean for the Stock? - Yahoo Finance
Farm Hands on the Potomac: Modisett Kemp to lead government affairs at Corteva, Simpson assumes leadership of NCFC - Agri-Pulse
Fund Update: Ballentine Partners, LLC added 120,908 shares of CORTEVA ($CTVA) to their portfolio - Quiver Quantitative
Oppenheimer Adjusts Corteva Price Target to $87 From $75, Maintains Outperform Rating - MarketScreener
Corteva (CTVA) Partners Micropep Technologies on Sustainable Crop Protection - MSN
(CTVA) Pivots Trading Plans and Risk Controls - news.stocktradersdaily.com
Corteva Stock Slides 5.20% in Six Days, Trading Volume Drops to 451st Rank - AInvest
We Think Corteva (NYSE:CTVA) Can Stay On Top Of Its Debt - simplywall.st
KeyBanc Capital Adjusts Price Target on Corteva to $84 From $72, Maintains Overweight Rating - MarketScreener
Keybanc Analyst Raises Price Target for Corteva (CTVA) to $84 | - GuruFocus
Keybanc Analyst Raises Price Target for Corteva (CTVA) to $84 | CTVA Stock News - GuruFocus
Biological Nutrition Seed Treatment Supports Uniform Corn Emergence - Dakota News Network
Corteva stock price target raised to $85 from $74 at RBC Capital By Investing.com - Investing.com South Africa
A Glimpse Into The Expert Outlook On Corteva Through 14 Analysts - Benzinga
Corteva stock price target raised to $85 from $74 at RBC Capital - Investing.com Nigeria
RBC Raises Price Target on Corteva to $85 From $74, Keeps Outperform Rating - MarketScreener
Best Agriculture Stocks Worth WatchingJuly 9th - MarketBeat
CTVA: UBS Raises Corteva Price Target to $90 with Buy Rating | C - GuruFocus
UBS Increases Price Target for Corteva (CTVA) to $90 | CTVA Stoc - GuruFocus
CTVA: BMO Capital Raises Price Target for Corteva to $86 | CTVA Stock News - GuruFocus
Corteva Q2 Preview: Potential Benefit From Positive Biofuel Policy In Brazil (CTVA) - Seeking Alpha
BMO Capital raises Corteva stock price target to $86 on strong growth profile By Investing.com - Investing.com South Africa
Wells Fargo Hikes Corteva (CTVA) Price Target Affirms ‘Overweight’ Rating - MSN
BMO Capital raises Corteva stock price target to $86 on strong growth profile - Investing.com Canada
Are Consumer Staples Stocks Lagging Corteva (CTVA) This Year? - Yahoo Finance
Corteva (CTVA) Price Target Raised by Barclays to $75.00 | CTVA Stock News - GuruFocus
Corteva shares fall as earnings guidance disappoints By Investing.com - Investing.com Nigeria
Corteva (CTVA): New Buy Recommendation for This Basic Materials Giant - The Globe and Mail
Chemours, DuPont, Corteva Provide Update; Affirm Support for PFAS Settlement with U.S. Water Systems - global-agriculture.com
Corteva Receives Buy Rating from Citi Amid Insider Selling - AInvest
Agricultural Biotechnology Market Outlook Report to 2030, with Profiles of Bayer, Corteva, Syngenta, BASF, FMC, Bioceres Crop Solutions, Evogene, Marrone Bio Innovations, Calyxt & Arcadia Biosciences - GlobeNewswire
Here's How Much $100 Invested In Corteva 5 Years Ago Would Be Worth Today - Benzinga
New Buy Rating for Corteva (CTVA), the Basic Materials Giant - The Globe and Mail
Corteva Agriscience Signs Agreement to Acquire Biological Leader Symborg - global-agriculture.com
Corteva, Inc. (NYSE:CTVA) is largely controlled by institutional shareholders who own 87% of the company - simplywall.st
Corteva Increases Quarterly Dividend - global-agriculture.com
Gates Agricultural Innovations and Corteva Announce New Collaboration to Accelerate Ag Innovation - global-agriculture.com
Symbiomics Secures Strategic Investment from Corteva to Collaborate on Biologicals Innovation - AgriBusiness Global
Corteva stock hits all-time high at 74.97 USD - Investing.com
Navigating Uncertainty with Dividend Champions: Corteva and the Fed's Rate Outlook - AInvest
Micropep and Corteva Announce Multi-Year Research Collaboration to Advance Sustainable Biocontrol Solutions - BioSpace
From Weaver Seed Co. to Pioneer to Corteva Agriscience, Grand Rapids plant celebrates 50-year history - BG Independent News
Micropep and Corteva Launch Multi-Year Partnership to Develop Sustainable Biocontrol Solutions - AgriBusiness Global
Corteva, Micropep Enter Multiyear Deal to Develop Peptide-Based Biofungicides - MarketScreener
Micropep and Corteva partner on peptide-based crop protection By Investing.com - Investing.com Nigeria
Micropep and Corteva partner on peptide-based crop protection - Investing.com Australia
Corteva (CTVA) Partners with Micropep for Innovative Biocontrol Solutions | CTVA Stock News - GuruFocus
Micropep and Corteva Announce Multi-Year Research Collaboration to Advance Sustainable Biocontrol Solutions | CTVA Stock News - GuruFocus
Finanzdaten der Corteva Inc-Aktie (CTVA)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.24%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):